LB Pharmaceuticals, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Holding
- Established
- 2015-09-01
- Employees
- 11
- Market Cap
- -
- Website
- http://www.lbpharma.us
Clinical Trials
3
Active:0
Completed:3
Trial Phases
2 Phases
Phase 1:2
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 1
2 (66.7%)Phase 2
1 (33.3%)Randomized, Double-blinded, Placebo-controlled, Evaluating the Treatment With LB-102 in Patients With Acute Schizophrenia
- First Posted Date
- 2023-12-21
- Last Posted Date
- 2025-04-29
- Lead Sponsor
- LB Pharmaceuticals Inc.
- Target Recruit Count
- 359
- Registration Number
- NCT06179108
- Locations
- 🇺🇸
Pillar Clinical Research, Richardson, Texas, United States
🇺🇸Woodland Internation Research Group, Little Rock, Arkansas, United States
🇺🇸Woodland Research Northwest, Rogers, Arkansas, United States
Receptor Occupancy of LB-102 Using Positron Emission Tomography (PET) in Healthy Volunteers
- First Posted Date
- 2020-10-19
- Last Posted Date
- 2022-05-04
- Lead Sponsor
- LB Pharmaceuticals Inc.
- Target Recruit Count
- 16
- Registration Number
- NCT04588129
- Locations
- 🇺🇸
Washington University School of Medicine, Saint Louis, Missouri, United States
Safety and Tolerability of Single and Multiple Doses of LB-102 in Healthy Adults
- First Posted Date
- 2019-12-05
- Last Posted Date
- 2020-12-10
- Lead Sponsor
- LB Pharmaceuticals Inc.
- Target Recruit Count
- 64
- Registration Number
- NCT04187560
- Locations
- 🇺🇸
Medpace Clinical Pharmacology LLC, Cincinnati, Ohio, United States
News
No news found